Women's health · Menopause and genitourinary symptoms
Genitourinary Syndrome of Menopause: Vaginal and Urinary Symptoms, Options, and Safety
Dryness, irritation, discomfort with sex, urgency, or repeated urinary infections may be part of genitourinary syndrome of menopause (GSM)—but similar symptoms can have other causes. Learn what the term means, what options are discussed, and when to seek assessment.
A common menopause concern that is often left unspoken
Menopause conversations often focus on hot flashes and sleep, while genital or urinary changes can feel too private to mention. Yet dryness, irritation, discomfort during sex, or a sudden need to urinate can affect everyday comfort and relationships. These symptoms are not a personal failing, and people do not have to simply accept them. A useful starting point is to know the name used for a group of changes—genitourinary syndrome of menopause, or GSM—and to remember that the label is a framework, not a diagnosis made from a checklist. Similar symptoms can have other explanations, so a qualified healthcare professional can help decide what deserves attention.
What genitourinary syndrome of menopause means
The Office on Women’s Health (OWH), part of the U.S. Department of Health and Human Services, explains that lower estrogen levels can affect tissues of the vagina, vulva, bladder, and urinary tract. Providers use GSM for genital and urinary symptoms associated with menopause. It can begin around perimenopause or later; the term describes a cluster rather than one single sensation. The Menopause Society also lists genitourinary symptoms among changes that may occur during the menopause transition. Neither source says that every urinary or vaginal symptom in a midlife person is caused by menopause. The wording is useful because it gives patients and clinicians a shared topic to discuss, not because it replaces evaluation.
Which changes people may notice
Possible symptoms include vaginal dryness; burning, itching, or irritation around the vagina or vulva; discomfort or pain with sex; urinary urgency or frequency; and recurrent urinary tract infections (UTIs). A person may notice one, several, or changing symptoms. Some people primarily experience dryness, while others are more troubled by urinary changes. There is no single pattern that confirms GSM at home. A symptom list can help someone explain what is happening, but it cannot distinguish a menopause-related tissue change from infection, skin conditions, medication effects, or another health issue. Naming a concern is useful; presuming its cause is not.
Why symptoms deserve context rather than assumptions
People sometimes feel embarrassed or assume that discomfort is inevitable with age. Others may worry that a urinary symptom means an infection, or that pain with sex must be endured. It is reasonable to bring these concerns to a clinician; they are common topics in menopause care. Symptoms may affect sleep, intimacy, exercise, or confidence, and that impact is worth describing. At the same time, dryness, itching, pain, and urgency are not specific to GSM. Infection, vulvar skin disorders, sexually transmitted infections, pelvic floor concerns, and other conditions can produce overlapping symptoms. A careful assessment is especially valuable when symptoms are new, persistent, worsening, or not responding as expected.
A first conversation can be practical and focused
A first appointment can be straightforward. A clinician may ask when the symptoms began, what makes them better or worse, whether there is pain, discharge, urinary burning, blood, or fever, and whether a person is using hormone therapy or other medicines. Depending on the concern, an examination or tests may be discussed; what is appropriate varies with the symptoms and health history. People can ask why a proposed test is being considered and what it can show. If an examination is uncomfortable, difficult, or distressing, say so and ask about pacing, explanation, a support person, or other accommodations available locally. No one needs to choose a treatment before understanding the options.
Nonprescription comfort measures have different roles
For vaginal dryness or discomfort, nonprescription products may be part of a conversation. OWH distinguishes vaginal moisturizers, which are used regularly, from personal lubricants that can reduce friction during sexual activity. Its guidance describes moisturizers used every few days and water-based lubricant during sex as examples; product directions differ, and an individual can ask a clinician or pharmacist which type is suitable. These products are not the same as prescription treatment and do not identify the cause of symptoms. Products designed for vaginal use are preferable to fragranced or irritating products; stop using anything that causes burning or a rash and ask for advice if symptoms persist. Do not douche or insert household products.
Prescription options are not one-size-fits-all
Prescription treatments can be considered when symptoms are bothersome, but the choice depends on a person’s history, preferences, and clinical situation. OWH lists vaginal estrogen in forms such as cream, tablet, insert, or ring, as well as vaginal dehydroepiandrosterone (DHEA, also called prasterone) for vaginal dryness and pain with sex related to menopause. It also lists ospemifene, a prescription pill that acts like estrogen on vaginal tissue. These are examples of clinician-discussed options, not recommendations for a particular reader. They differ in how they are used, potential risks, and suitability. A clinician can explain likely benefits, uncertainties, alternatives, and follow-up. Do not start, stop, share, or change prescription treatment based on this article.
A history of breast cancer calls for coordinated advice
Hormone decisions require personal context. OWH notes that vaginal hormones come in several forms and that a provider can help choose a product and dose. It specifically advises people who have or have had breast cancer to talk with their cancer care team before using hormone therapy, including vaginal estrogen. A history of hormone-sensitive cancer, current cancer treatment, unexplained bleeding, blood clots, or other significant health issues should be mentioned when discussing options. The information here cannot determine whether a treatment is appropriate or risk-free for an individual. When more than one professional is involved, it can help to coordinate the conversation so the people advising on menopause symptoms and cancer care can consider the same history.
Urinary symptoms need their own assessment
Urinary urgency, frequency, pain, or repeated UTIs deserve a thoughtful assessment rather than being automatically attributed to GSM. A urinary infection can need testing and treatment, and other bladder or pelvic conditions can overlap. If symptoms include burning when urinating, cloudy or bloody urine, fever, chills, back or side pain, or a marked change in how someone feels, contact a qualified healthcare service for advice. A clinician can decide whether a urine test or another evaluation is appropriate. This article cannot tell whether a reader has a UTI, whether infections are recurrent, or what treatment is needed. Do not use leftover antibiotics or someone else’s medicine, and do not delay care for severe or rapidly worsening symptoms.
Energy-based vaginal procedures are not established care
Some clinics advertise vaginal laser or radiofrequency procedures for menopause-related symptoms. OWH says energy-based vaginal treatments are not recommended for GSM because they have not been shown to work better than placebo and may cause vaginal pain and scarring; the FDA has not authorized these devices for treatment of GSM. This is a useful reminder to ask what evidence supports a proposed procedure, what authorization applies, what harms are known, and what alternatives exist. Marketing terms such as “rejuvenation” do not establish that a treatment is safe or effective. Readers should not interpret this article as a personal recommendation about any procedure; a clinician who knows the individual situation can discuss available options and uncertainties.
What to record before an appointment
A few notes can make a conversation more useful. Consider writing down the main symptom, when it began, how often it occurs, and how it affects daily life or sex. Note whether there is pain, itching, discharge, urinary leakage, burning, urgency, fever, or blood, and whether symptoms change after a product or medicine. List relevant prescriptions, over-the-counter products, and supplements, along with prior cancer treatment or other important health history. A simple record is not a diagnostic tool and should not delay care if symptoms are severe. It gives a clinician a clearer account and helps make sure that the most bothersome concern is addressed first.
Questions that help clarify a shared plan
Questions can help turn an appointment into a shared plan: What possible causes fit these symptoms? Do I need an examination or test, and what would it clarify? Could a medicine or another condition contribute? Which nonprescription or prescription options are appropriate to discuss for my history? How should I use a product, what side effects need attention, and when should we check in? If symptoms continue, whom should I contact? People can also ask about costs, privacy, interpreters, and accommodations. The right plan is not the one that sounds most modern or is promoted most strongly; it is one the patient and clinician understand, including expected benefits, limits, and follow-up.
Bleeding and other warning signs should not be self-labeled
Bleeding after menopause should not be written off as GSM. OWH states that vaginal bleeding after 12 months without a period is not normal and should be discussed with a healthcare provider right away. A previous article on this site covers why postmenopausal bleeding deserves assessment. New or unexplained bleeding, blood in urine, persistent unusual discharge, a new lump or sore, severe pelvic pain, fever with urinary symptoms, inability to urinate, or rapidly worsening illness may need prompt or urgent assessment depending on severity and local guidance. This is not a complete triage list. If a symptom feels severe or urgent, contact local medical services rather than relying on an online guide to determine what is happening.
Keep optional wellness programs separate from medical evidence
This site has an existing program page called The Menopause Solution. The three links below are optional navigation to that existing commercial resource for readers who wish to review its published scope. It was not used as a source for the health information here and is not a diagnostic service or a substitute for clinical care. No claim is made that purchasing a program treats GSM, prevents infection, or replaces a clinician’s assessment. Keep evidence-based medical questions separate from promotional materials, and be cautious of any product that promises a guaranteed cure, asks someone to stop prescribed care, or discourages assessment of new symptoms.
The practical takeaway
GSM is a name for genital and urinary symptoms that can be associated with menopause, and effective options may be available. The most helpful next step depends on what is happening and on a person’s health history; dryness, pain, urgency, or recurrent urinary symptoms do not prove the cause. A clinician can help distinguish possible explanations and discuss comfort measures or prescription choices, including their limits and risks. Mention cancer history and other important conditions before considering hormone treatment, and seek assessment for new bleeding after menopause or concerning urinary symptoms. The aim is not to prescribe a solution from a webpage, but to make a clear, informed conversation easier.
Editorial note and disclaimer
Editorial review by Mr.Hotsia was limited to sourcing and clarity. It was not a clinical review, and Mr.Hotsia is not presented as a healthcare professional. This article is general health information, not personal medical advice, diagnosis, or a treatment plan. It does not replace assessment by a qualified healthcare professional.
Sources and further reading
Medical information was checked against these public health sources on November 3, 2026.
- Office on Women's Health, U.S. Department of Health and Human Services — Menopause symptoms and relief (updated October 19, 2026) ↗
- Office on Women's Health, U.S. Department of Health and Human Services — Menopause treatment (updated October 19, 2026) ↗
- The Menopause Society — Menopause symptoms ↗
- NIDDK, National Institutes of Health — Symptoms and causes of bladder infection in adults (reviewed April 2024) ↗
- NIDDK, National Institutes of Health — Symptoms and causes of kidney infection (reviewed October 2024) ↗
This article is general health education, not a diagnosis or personal medical advice. Do not change treatment or supplements based on this article. Discuss individual results with a qualified healthcare professional.